NCT04238000

Brief Summary

Objective of the study: To test the efficacy of theta burst cerebellar stimulation on dual task walking in Parkinson's disease using a cross-over design and wearing sensors technology Design: Twenty Parkinson's disease patients with no dementia will be recruited for a cross-over sham-controlled study. Each patient will undergo a sham stimulation or a single session of cerebellar theta burst stimulation with a wash out period of at least 14 days. Each patient will be evaluated before and after stimulation by a battery of gait and movement tests using wearing sensors technology .

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2018

Completed
2 years until next milestone

First Submitted

Initial submission to the registry

January 18, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

January 23, 2020

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2020

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2020

Completed
Last Updated

January 23, 2020

Status Verified

January 1, 2020

Enrollment Period

2.2 years

First QC Date

January 18, 2020

Last Update Submit

January 18, 2020

Conditions

Keywords

repetitive Transcranial Magnetic stimulationrTMSwearing sensorswearablesstep variabilitygait variabilitygait speeddual-taskdual-task walkingturning

Outcome Measures

Primary Outcomes (3)

  • Step variability in dual-task walking

    Step variability will be assessed in normal, cognitive/motor dual-task conditions walking

    Changes from Baseline to immediately after stimulation

  • Step length in dual-task walking

    Step length will be assessed in normal, cognitive/motor dual-task conditions

    Changes from Baseline to immediately after stimulation

  • Gait speed in dual-task walking

    Gait speed will be assessed in normal, cognitive/motor dual-task conditions

    Changes from Baseline to immediately after stimulation

Secondary Outcomes (2)

  • Turning speed in timed up and go tests

    Changes from Baseline to immediately after stimulation

  • total distance of dual-task walking

    Changes from Baseline to immediately after stimulation

Study Arms (2)

Real Stimulation

ACTIVE COMPARATOR

Cerebellar Repetitive theta burst stimulation will be performed using a 3 pulses at 50-Hz repeated at a rate of 5-Hz; 20 trains of 10 bursts given with 8-s intervals for a total of 600 pulses. Intensity of rTMS was set at the 80% of Amplitude of Motor Threshold (RMT) obtained in the left motor cortex for each subject.

Device: repetitive transcranial magnetic stimulation

Sham Stimulation

PLACEBO COMPARATOR

The rTMS coil stimulation will be applied in the same position of the real stimulation. The Stimulation will be performed like in the real arm with the difference that the coil will be masked and thus will be inactive. The patient will hear the same sound of real stimulation, which will be only functionally inactive but will be completely performed (for the whole time of duration of stimulation)

Device: repetitive transcranial magnetic stimulation

Interventions

Cerebellar repetitive theta Burst stimulation will be performed as detailed in the Real arm description

Real StimulationSham Stimulation

Eligibility Criteria

Age40 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • established Parkinson's disease
  • ability to stand alone and walk without support

You may not qualify if:

  • dementia or behavioral alterations
  • contraindication to stimulation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Parkinson's disease Rehabilitation Centre - FERB ONLUS

Trescore Balneario, Italy

RECRUITING

MeSH Terms

Conditions

Parkinson DiseaseGait Disorders, NeurologicParkinsonian Disorders

Interventions

Transcranial Magnetic Stimulation

Condition Hierarchy (Ancestors)

Basal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Magnetic Field TherapyTherapeutics

Study Officials

  • Andrea Pilotto, MD

    FERB Onlus

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Cristina Rizzetti

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
The patient and the examiner who administered the clinical scales were blind to the type of rTMS delivered, which was applied by another blinded experimenter.
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: Each patient received both rTMS and sham cerebellar stimulation in randomized order in two different sessions, separated by at least 2 weeks. In each session, motor tasks, clinical scales and wearing sensor assessments were tested twice in all patients: at baseline (pre-stimulation) and after rTMS (post-stimulation)
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Parkinson's disease Rehabilitation Centre

Study Record Dates

First Submitted

January 18, 2020

First Posted

January 23, 2020

Study Start

January 1, 2018

Primary Completion

April 1, 2020

Study Completion

June 1, 2020

Last Updated

January 23, 2020

Record last verified: 2020-01

Data Sharing

IPD Sharing
Will share

The whole study will be published in medical journal

Shared Documents
STUDY PROTOCOL, SAP, ANALYTIC CODE
Time Frame
In the publication, within the next year
Access Criteria
on line availability

Locations